Tumor suppressor may actually fuel aggressive leukemia
Tuesday, August 27, 2013 - 13:00
in Health & Medicine
New research suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia. The protein scientists targeted is a transcription factor known as RUNX1, which also plays an important role in helping regulate the normal development of blood cells.